Back

NT-proBNP is a more sensitive and specific biomarker for the prediction of future atrial fibrillation than for forthcoming onset of heart failure: results from the observational DIAST-CHF study

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Biomarkers - Heart Failure Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Miss Stefanie Maria Werhahn

German Heart Centre Berlin, Berlin (Germany)

7 More presentations in this session

Presentation thumbnail
Plasma trimethylamine-N-oxide is associated with atrial fibrillation
Doctor G. Svingen (Bergen, NO)
Abstract
Presentation thumbnail
Elevated levels of BNP and fibroblast growth factor 23 in patients with atrial fibrillation : an analysis of 40 cardiovascular biomarkers in 667 unselected hospitalized patients.
Doctor Y. Purmah (Birmingham, GB)
Abstract
Presentation thumbnail
Circulating lipopolysaccharides and risk of major adverse cardiovascular events in atrial fibrillation: association with mediterranean diet adherence
Associate Professor D. Pastori (Rome, IT)
Abstract Slides
Presentation thumbnail
Effect of rivaroxaban on coagulation and inflammation biomarkers: results from an X-VeRT substudy
Doctor Y. Purmah (Birmingham, GB)
Abstract
Presentation thumbnail
Preferential association of biomarkers with post-ablation recurrence in non-paroxysmal atrial fibrillation indicates the role of inflammation in persistence of the arrhythmia
Doctor S. Mohanty (Austin, US)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Biomarkers - Heart Failure

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources